{"article_title": "The FDA Should Enable Biosimilars And Foster A More Competitive Biologics Market", "article_keywords": ["fda", "enable", "biosimilars", "biologics", "foster", "competitive", "market"], "article_url": "http://www.forbes.com/sites/econostats/2014/12/10/the-fda-should-enable-biosimilars-and-foster-a-more-competitive-biologics-market/", "article_text": "", "article_metadata": {"prerender-status-code": "{{meta.code}}", "author": "EconoSTATS", "og": {"site_name": "Forbes", "description": "By Wayne Winegarden Negative health care news continue to dominate the headlines. And, deservedly so. Thanks to the Affordable Care Act, health care is now less affordable, not more so. It has also increased the healthcare system\u2019s complexity and worsened the adverse incentives plaguing the U.S. healthcare industry. There are, however, some [...]", "title": "The FDA Should Enable Biosimilars And Foster A More Competitive Biologics Market", "url": "http://www.forbes.com/sites/econostats/2014/12/10/the-fda-should-enable-biosimilars-and-foster-a-more-competitive-biologics-market/", "image": "http://i.forbesimg.com/media/assets/forbes_1200x1200.jpg", "updated_time": "2014-12-10T11:25:55-05:00", "type": "article"}, "twitter": {"image": "http://i.forbesimg.com/media/assets/forbes_1200x1200.jpg", "title": "The FDA Should Enable Biosimilars And Foster A More Competitive Biologics Market", "description": "By Wayne Winegarden Negative health care news continue to dominate the headlines. And, deservedly so. Thanks to the Affordable Care Act, health care is now less affordable, not more so. It has also increased the healthcare system\u2019s complexity and worsened the adverse incentives plaguing the U.S. healthcare industry. There are, however, some [...]", "card": "summary_large_image", "site": "@forbes"}, "description": "By Wayne Winegarden Negative health care news continue to dominate the headlines. And, deservedly so. Thanks to the Affordable Care Act, health care is now less affordable, not more so. It has also increased the healthcare system\u2019s complexity and worsened the adverse incentives plaguing the U.S. healthcare industry. There are, however, some [...]", "apple-itunes-app": "app-id=588647136", "fb": {"app_id": 123694841080850}, "keywords": "Law,OpEd,Law &amp; Regulation,Op/Ed", "article": {"publisher": "https://www.facebook.com/forbes", "section_url": "http://www.forbes.com/opinion", "section": "Opinion", "modified": "2014-12-10", "published": "2014-12-10", "id": "blogAndPostId/blog/post/2311-345"}, "viewport": "width=device-width,initial-scale=1,maximum-scale=1,user-scalable=no", "news_keywords": "Law,OpEd,Law &amp; Regulation,Op/Ed"}, "_id": "\"57477af46914bd0286fdf31a\"", "article_summary": ""}